Innoviva, Inc. (INVA)
NASDAQ: INVA · Real-Time Price · USD
18.49
-0.54 (-2.84%)
Nov 16, 2026, 4:00 PM EST - Market closed

Innoviva Revenue

Innoviva had revenue of $106.12M in the quarter ending September 30, 2026, a decrease of -1.56%. This brings the company's total for the last twelve months to $438.32M, up 12.82% year-over-year. In the year 2025, Innoviva had annual revenue of $411.33M with 14.67% growth. That makes Innoviva the 12,042nd largest company in the world by revenue and 2,369th in the United States.

Revenue (ttm)
$438.32M
Revenue Growth
+12.82%
P/S Ratio
3.00
Revenue / Employee
$2,756,717
Employees
159
Market Cap
1.31B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025411.33M52.62M14.67%
Dec 31, 2024358.71M48.25M15.54%
Dec 31, 2023310.46M-20.88M-6.30%
Dec 31, 2022331.34M-60.53M-15.45%
Dec 31, 2021391.87M55.07M16.35%
Dec 31, 2020336.79M75.78M29.03%
Dec 31, 2019261.02M12.00K-
Dec 31, 2018261.00M43.79M20.16%
Dec 31, 2017217.22M83.65M62.63%
Dec 31, 2016133.57M79.62M147.58%
Dec 31, 201553.95M45.52M539.74%
Dec 31, 20148.43M3.90M86.08%
Dec 31, 20134.53M-1.08M-19.26%
Dec 31, 20125.61M-18.90M-77.10%
Dec 31, 201124.51M289.00K1.19%
Dec 31, 201024.22M-151.00K-0.62%
Dec 31, 200924.37M1.28M5.53%
Dec 31, 200823.10M1.09M4.97%
Dec 31, 200722.00M2.42M12.33%
Dec 31, 200619.59M7.53M62.49%
Dec 31, 200512.05M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
MannKind413.37M
Novavax411.65M
Nuvation Bio201.73M
Ocular Therapeutix50.38M
Generate Biomedicines21.07M
Taysha Gene Therapies5.49M
Absci1.49M
Revenue Rankings